Quick Answer
Turn Therapeutics Inc. reported Stockholders Equity of $4.69 million for fiscal year 2025.
Turn Therapeutics Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $4.69M | +2741.4% |
| 2024 | -$177.4K | -306.9% |
| 2023 | $85.8K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $504.0K | +221.7% | +384.1% |
| December 31, 2024 | -$177.4K | -306.9% | +57.2% |
| September 30, 2024 | -$414.3K | — | -583.0% |
| December 31, 2023 | $85.8K | — | — |
- Turn Therapeutics Inc. showed an increase of +2741.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2023–2025 period, Turn Therapeutics Inc.’s stockholders equity has grown by 5364.4% (from $85.8 thousand to $4.69 million).
- The most recent figure is from Turn Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: